Previous 10 | Next 10 |
2023-06-02 23:58:15 ET Summary ICON PLC shares set higher lows in June, and the company presents strong fundamentals and economic earnings for shareholders. ICLR has shown robust financial performance, with a 9% YoY increase in revenue and a 200bps expansion in gross margin YoY. ...
ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023 at 2:40pm CT and Mr. Brendan Brenna...
2023-05-26 09:18:10 ET FTSE Russell will rebalance its indexes at the end of June and, as usual, a great deal of buying and selling will come from mutual funds and ETFs to track those changes. The preliminary list of changes came out last week, using April 28 for a cutoff date for marke...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its ICON Cares 2022 Environmental, Social and Governance (ESG) Report . The company’s ICON Cares initiative incorporates its ESG, Diversity, Inclusion and Belonging an...
2023-05-10 09:41:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund® (the Fund) was up 9.44% (Institutional Shares) in the first...
2023-04-27 14:33:00 ET IQVIA Holdings ( NYSE: IQV ) and ICON Public Limited ( NASDAQ: ICLR ) led decliners in the contract research space Thursday after the companies reiterated the guidance despite reporting better-than-expected Q1 2023 financials. IQV shares have reach...
2023-04-27 14:22:10 ET ICON Public Limited Company (ICLR) Q1 2023 Earnings Conference Call April 27, 2023, 08:00 AM ET Company Participants Kate Haven - VP of IR Steve Cutler - CEO Brendan Brennan - CFO Conference Call Participants John Sourbeer - UBS...
2023-04-26 16:36:34 ET Icon press release ( NASDAQ: ICLR ): Q1 Non-GAAP EPS of $2.90 beats by $0.03 . Revenue of $1.98B (+4.2% Y/Y) in-line. Net business wins in the quarter of $2,415 million; a net book to bill of 1.22. Closing backlog of $21.2 billion, an inc...
Highlights Net business wins in the quarter of $2,415 million; a net book to bill of 1.22. Closing backlog of $21.2 billion, an increase of 2.4% on quarter four 2022 or an increase of 8.4% on quarter one 2022. First quarter revenue of $1,978.6 million representing an increase of 4...
2023-04-25 17:35:57 ET Icon ( NASDAQ: ICLR ) is scheduled to announce Q1 earnings results on Wednesday, April 26th, after market close. The consensus EPS Estimate is $2.87 (+4.0% Y/Y) and the consensus Revenue Estimate is $1.98B (+4.2% Y/Y). Over the last 2 years, ICLR...
News, Short Squeeze, Breakout and More Instantly...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...